IDiyas

For the Inventor, By the Inventor

Vienna, Austria

Novartis Pharma Gmbh


USPTO Granted Patents = 8


Forward Citations = 49


where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents


507 inventors (with patents filed for the assignee):

goldMedal Paul William Manley (2 out of 63 patents)

silverMedal Paul Allen Sutton (2 out of 18 patents)

bronzeMedal Wen-Chung Shieh (2 out of 21 patents)

4.  Raeann Wu (2 out of 12 patents)

5.  Stéphanie Monnier (2 out of 10 patents)

6.  Jörg Brozio (2 out of 7 patents)

7.  Michael Mutz (2 out of 25 patents)

8.  Michael P Cooreman (1 out of 2 patents)

9.  Piotr Henryk Karpinski (1 out of 23 patents)

10.  Hermann Gram (1 out of 19 patents)

11.  Dieter Welzel (1 out of 7 patents)

12.  Franco E Di Padova (1 out of 17 patents)

13.  Thomas Jung (1 out of 9 patents)

14.  Timothy Wright (1 out of 4 patents)

15.  Trevor Mundel (1 out of 3 patents)


8 patents:

1. 8343984 - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide (2013-01-01),
2. 8198289 - Crystal form H imatinib mesylate for pharmaceutical use (2012-06-12),
3. 8163904 - Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-Benzamide (2012-04-24),
4. 8105587 - Methods of treating arthritis using IL-1β binding molecules (2012-01-31),
5. 8012477 - Methods of treating multiple myeloma using IL-17 binding molecules (2011-09-06),
6. 7998687 - Biomarkers for chronic transplant dysfunction (2011-08-16),
7. 7893076 - Crystalline form F of Imatinib mesylate (2011-02-22),
8. 6740672 - Use of 5HT3-receptor antagonists for the treatment of chronic fatigue syndrome (2004-05-25),
Novartis Pharma GmbH is a subsidiary of Novartis AG, a global healthcare company that provides solutions to address the evolving needs of patients worldwide. Novartis Pharma GmbH focuses on innovative medicines, offering a wide range of products across multiple therapeutic areas such as oncology, cardiovascular, and neuroscience. The company is committed to research and development to improve health outcomes and quality of life for patients.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

8 Patents

#85 in Vienna

#375 in Austria

...
Vienna, Austria

Novartis Pharma Gmbh

Forward Citations = 49

507 inventors:

goldMedal Paul William Manley (2 out of 63 patents)

silverMedal Paul Allen Sutton (2 out of 18 patents)

bronzeMedal Wen-Chung Shieh (2 out of 21 patents)

4.  Raeann Wu (2 out of 12 patents)

5.  Stéphanie Monnier (2 out of 10 patents)

Please report any incorrect information to support@idiyas.com
Loading…